Church & Dwight Co., Inc. (NYSE:CHD) Shares Sold by Banco Bilbao Vizcaya Argentaria S.A.

Banco Bilbao Vizcaya Argentaria S.A. cut its holdings in shares of Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 33.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,043 shares of the company's stock after selling 2,591 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Church & Dwight were worth $528,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of CHD. YANKCOM Partnership purchased a new stake in shares of Church & Dwight in the fourth quarter valued at approximately $25,000. Versant Capital Management Inc increased its holdings in Church & Dwight by 224.4% in the 4th quarter. Versant Capital Management Inc now owns 266 shares of the company's stock worth $28,000 after acquiring an additional 184 shares in the last quarter. Bernard Wealth Management Corp. acquired a new position in Church & Dwight during the fourth quarter worth $40,000. Bank of Jackson Hole Trust purchased a new position in Church & Dwight during the fourth quarter valued at $43,000. Finally, Golden State Wealth Management LLC acquired a new stake in shares of Church & Dwight in the fourth quarter valued at about $51,000. Hedge funds and other institutional investors own 86.60% of the company's stock.

Insider Activity

In other news, EVP Rene Hemsey sold 11,060 shares of the firm's stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $109.98, for a total value of $1,216,378.80. Following the transaction, the executive vice president now directly owns 6,437 shares in the company, valued at $707,941.26. This trade represents a 63.21 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Maynadier Patrick D. De sold 54,510 shares of the business's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $115.98, for a total value of $6,322,069.80. Following the transaction, the executive vice president now owns 10,497 shares in the company, valued at approximately $1,217,442.06. This represents a 83.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 65,570 shares of company stock valued at $7,538,449 over the last quarter. Corporate insiders own 2.00% of the company's stock.

Church & Dwight Trading Down 7.0 %

NYSE:CHD traded down $6.93 on Thursday, reaching $92.41. 4,640,399 shares of the company's stock were exchanged, compared to its average volume of 1,571,000. The business has a fifty day moving average of $106.51 and a 200-day moving average of $106.07. The company has a quick ratio of 1.24, a current ratio of 1.70 and a debt-to-equity ratio of 0.51. Church & Dwight Co., Inc. has a 52-week low of $91.73 and a 52-week high of $116.46. The firm has a market capitalization of $22.74 billion, a price-to-earnings ratio of 38.99, a price-to-earnings-growth ratio of 3.32 and a beta of 0.55.

Church & Dwight (NYSE:CHD - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. The company had revenue of $1.47 billion during the quarter, compared to analysts' expectations of $1.52 billion. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. The firm's revenue was down 2.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.96 EPS. As a group, analysts expect that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current year.

Church & Dwight Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 2nd. Stockholders of record on Thursday, May 15th will be paid a dividend of $0.295 per share. This represents a $1.18 annualized dividend and a dividend yield of 1.28%. The ex-dividend date of this dividend is Thursday, May 15th. Church & Dwight's dividend payout ratio (DPR) is presently 49.79%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. UBS Group raised their price target on shares of Church & Dwight from $109.00 to $110.00 and gave the company a "neutral" rating in a research note on Thursday, April 17th. Piper Sandler dropped their price target on Church & Dwight from $128.00 to $126.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. Barclays reduced their price objective on Church & Dwight from $97.00 to $94.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. Bank of America raised shares of Church & Dwight from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $112.00 to $125.00 in a research note on Tuesday, April 15th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Church & Dwight from $106.00 to $98.00 and set an "underweight" rating for the company in a research report on Friday, April 11th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, Church & Dwight presently has an average rating of "Hold" and a consensus price target of $112.29.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.